Tempest Therapeutics Director John D. Yee Files Late Form 3 for Beneficial Ownership

John D. Yee, a director of Tempest Therapeutics, Inc. (TPST), has filed a late Form 3 statement of beneficial ownership. The filing reports Yee's ownership of securities in the company and is being submitted after the required deadline due to an inadvertent administrative oversight. The period of report is June 4, 2026, with the document signed on June 17, 2026. As a director, Yee is required to disclose his beneficial ownership of Tempest Therapeutics securities. The filing indicates ownership of securities but does not specify the exact number or type of securities held. This late filing represents a compliance issue but appears to be an administrative error rather than intentional non-compliance.